ABOUT US > Company profile
Biocellvia is a pioneer in compound validation assay development.
« Our technology is the guarantee of the same accuracy and reliability all along your research proceedings. »
Yvon JULE, co-founder and CSO
BASED ON DIGITAL IMAGING ANALYSIS OF TISSUES
While histological image analysis still currently uses the scoring method to evaluate morphological changes in tissues, Biocellvia’s investigations have been based on automated micro-computed imaging analysis.
FOR A CLEARER DECISION-MAKING IN COMPOUND EVALUATION
Biocellvia’s digital imaging technology provides robust investigative tools for preclinical research with:
- Fully automated analysis processings allowing a very fast assessment of the efficacy of compounds.
- Accurate and reproducible data, which allow to make an informed decision regarding the next steps of the research project.